CHICAGO, May 26 (Reuters) - Abraxane, a new cancer drug designed to be less toxic than standard chemotherapy, did a better job of keeping cancer at bay in women whose breast cancer had spread, U.S.

For patients whose breast cancer converted from lymph node-positive to lymph node-negative disease after neoadjuvant chemotherapy, skipping adjuvant regional nodal irradiation (RNI) did not increase ...

Women in their 40s can benefit from regular breast cancer screening, researchers argue Nearly 3 in 4 women in their 40s discover they have breast cancer after developing symptoms That increases the ...

As October rolls out this year, it’s time to globally observe Breast Cancer Awareness Month, to raise public understanding of breast health and the importance of early detection. Breast cancer remains ...